Biocompatible HA-PBA/PVA Dual-Network Hydrogel Composite System: A Promising Localized Therapeutic Platform for Bladder Cancer
ACS Applied Bio Materials · 21.09.2026 · 9 (18) · 8843-8859
DOI: 10.1021/acsabm.6c01346 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 04.09.2026. Verfasst von Zihao Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 1 Minde Rd, Nanchang330006, Jiangxi, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Polyvinyl Alcohol, Hydrogels, Biocompatible Materials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Bladder cancer is among the most common malignancies of the urinary system and is characterized by high recurrence rates and unsatisfactory clinical outcomes. Current therapeutic strategies are limited by inadequate local efficacy, rapid drug loss caused by the bladder microenvironment, and systemic toxicity associated with conventional chemotherapy. In this study, we developed a localized therapeutic platform for bladder cancer based on a hyaluronic acid-phenylboronic acid/poly(vinyl alcohol) (HA-PBA/PVA) dual-network hydrogel incorporating liposomes co-loaded with resveratrol (Res) and gemcitabine (Gem). The hydrogel system was designed to provide sustained local drug delivery and improved intravesical retention. Physicochemical characterization demonstrated favorable injectability, self-healing capacity, mechanical stability, and pH-responsive sustained-release behavior. The embedded liposomes exhibited a uniform nanoscale size distribution and high drug encapsulation efficiency. In vitro studies showed that the composite hydrogel displayed good biocompatibility and significantly inhibited MB49 bladder cancer cell proliferation, induced apoptosis, and suppressed migration and invasion. In vivo evaluation further demonstrated favorable biosafety and enhanced antitumor efficacy of the hydrogel-based local delivery system. These findings indicate that the HA-PBA/PVA hydrogel-liposome composite system is a promising localized therapeutic strategy for bladder cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 1 Minde Rd, Nanchang330006, Jiangxi, China.
- Department of Surgery, Dongguan Hospital of Guangzhou University of Chinese Medicine, 2 Songshan Lake Avenue, Dongguan523220, Guangdong, China.
- Department of Thyroid Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 1 Minde Rd, Nanchang330006, Jiangxi, China.
- Department of Gastrointestinal Surgery, Department of General Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou510080, China.
ORCID-Profile: Xiaoqing Xi
Förderung
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Chen, Z., Li, J., Hu, H., Zhang, Y., Zhang, C., Lin, J., & Xi, X. (2026). Biocompatible HA-PBA/PVA Dual-Network Hydrogel Composite System: A Promising Localized Therapeutic Platform for Bladder Cancer. ACS Applied Bio Materials, 9(18), 8843-8859. https://doi.org/10.1021/acsabm.6c01346
Vancouver
Chen Z, Li J, Hu H, Zhang Y, Zhang C, Lin J, et al. Biocompatible HA-PBA/PVA Dual-Network Hydrogel Composite System: A Promising Localized Therapeutic Platform for Bladder Cancer. ACS Applied Bio Materials. 2026;9(18):8843-8859. doi:10.1021/acsabm.6c01346
BibTeX
@article{Chen2026,
author = {Chen, Zihao and Li, Jiaxin and Hu, Hong and Zhang, Yunfeng and Zhang, Chenxi and Lin, Jiatong and Xi, Xiaoqing},
title = {Biocompatible HA-PBA/PVA Dual-Network Hydrogel Composite System: A Promising Localized Therapeutic Platform for Bladder Cancer},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {18},
pages = {8843--8859},
doi = {10.1021/acsabm.6c01346}
}
EUVIMED